Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children
Filetype[PDF-1.60 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.60 MB]
    Published Date:
    October 3, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.
    Description:
    On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine, DTaP-IPV (Kinrix, GlaxoSmithKline Biologicals, Rixensart, Belgium)...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.60 MB]
  2. Filetype[PDF - 86.94 KB]
    Personal Author:
    Oliver, Sara E.; Moore, Kelly L.;
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.
    Published Date:
    February 07 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(5):136-139
    Description:
    On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningococ...
    File Type:
    Filetype[PDF - 86.94 KB]
  3. Filetype[HTM]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    August 7, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(30):829-30.
    Description:
    This report updates Advisory Committee on Immunization Practices (ACIP) recommendations for routine poliovirus vaccination. These updates aim to 1) emphasize the importance of the booster dose at age >/=4 years, 2) extend the minimum interval from do...
    Status:
    current
    File Type:
    Filetype[HTM]
  4. Filetype[PDF - 371.67 KB]
    Personal Author:
    Lee, Andrew W.
    Corporate Authors:
    Merck Research Laboratories.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 October 21 : Atlanta, GA)
    Published Date:
    October 21, 2015
    Series:
    ACIP meeting Combination Vaccines
    File Type:
    Filetype[PDF - 371.67 KB]
  5. Filetype[PDF - 1022.57 KB]
    Personal Author:
    Goerke, L. S.; Roberts, Pauline; Chapman, John M.;
    Published Date:
    Jun 1958
    Source:
    Public Health Rep. 73(6):511-519
    File Type:
    Filetype[PDF - 1022.57 KB]